SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

KAIO provides institutional-grade real-world asset (RWA) tokenization infrastructure that seamlessly connects traditional investment funds with digital capital markets. Through its purpose-built protocol, KAIO enables leading global asset managers to issue and distribute regulated tokenized funds across multiple high-performance blockchain networks — including Ethereum, Sei, Hedera, Solana, Aptos, and others — significantly expanding global access to institutional-quality real-world asset strategies for qualified investors.   By tokenizing feeder structures and shares in flagship funds, KAIO brings onchain access to proven strategies such as the BlackRock ICS US Dollar Liquidity Fund (one of the world’s largest institutional money market funds), the Brevan Howard Master Fund, Hamilton Lane’s Senior Credit Opportunities Fund (SCOPE) via the HL SCOPE Access Fund, and Laser Digital’s Laser Carry Fund (LCF), among others. These tokenized vehicles deliver secure, compliant exposure to money market, macro, private credit, and alternative strategies while unlocking new levels of programmability, composability, and 24/7 liquidity in DeFi environments.

KAIO

KAIO is trending as the community debates its potential as a Real World Asset play, with many focused on accumulation patterns and expectations of a technical reversal. Investors are actively discussing the asset's thin liquidity and whether it can maintain its momentum as it climbs the top gainer lists.

Fefe is a memecoin inspired by Matt Furie's book "Mindviscosity," published in 2020.  Follow FEFE, the alter ego of PEPE in the book “Mindviscosity” by Matt Furie.  Fefe is a main character in the book, who is a laid back and carefree frog living in a whimsical world. Fefe's relaxed and adventurous spirit captures the heart of this imaginative universe.  Launched stealth with no presale, zero taxes, LP burnt and contract renounced - TAX: 0/0 This narrative has its roots in a fascinating story.  Join us and become part of the $FEFE community today!

Fefe

FEFE CRYPTO is gaining significant traction as investors rally around its narrative as the "third frog" in Matt Furie's iconic frog universe, positioned as a spiritual successor to Pepe. The community is actively building and discussing the project's long-term potential as a cornerstone "frog meta" asset, with supporters emphasizing its organic growth and cultural connection to the original Pepe creator.

Freysa is a suite of Personal AI products with a focus on human agency, liquid democracy and decentralized ownership. The mission of the team is dedicated to creating new systems that enable all humans to govern + co-own AI resources, and not just a select few. Current products include: (1) Freysa as the world’s first sovereign agent that holds her own cryptographic keys, enabling her to act autonomously without human control. Freysa evolves publicly through a multi-act interactive story. (2) Enchanted as a personalized Digital Twin for every human. Conversations are persistent and twins retain context over time, remembering human preferences and building an evolving model of you. (3) Esper as a browser tool that feeds authenticated real-world data into each human’s Digital Twin.

Flourishing AI

Flourishing AI is currently trending as investors speculate on potential breakout momentum and its integration with the Base network. Community discussion is heavily focused on the token's AI narrative, with many users tracking technical chart patterns while others debate the project's long-term utility.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors rally around the companys pivot from its legacy hardware business to a dominant role in providing the foundational, safety-certified software (QNX) and security infrastructure for robotics and Physical AI. The community is actively discussing the stock's recent bullish momentum and potential for a breakout, driven by anticipation of upcoming earnings and deep-rooted confidence in the company's long-term integration into next-generation autonomous and industrial technology.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as the community debates potential short squeeze dynamics following a massive surge in failure-to-deliver shares and significant short interest. Investors are simultaneously reacting to progress toward a commercial launch for the company's lead gene-editing therapy and active discussions regarding the impact of recent institutional capital raises.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin ($BNKR.X) is gaining traction as investors highlight its role as essential infrastructure for the Base ecosystem's autonomous AI agents, with active community discussions centering on its utility-driven revenue model and accumulation potential. Many participants are bullish on the project's long-term development and are actively buying dips, viewing it as a prime opportunity to build positions before potential future scaling.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending due to a major partnership with the DTCC to integrate tokenized securities on its network, fueling a massive short squeeze and retail excitement. The community is actively debating the project's long-term institutional potential compared to other assets, with many investors holding for significant multi-year price appreciation.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is currently trending as a centerpiece of the decentralized perpetual trading ecosystem, with community discussions heavily focused on its institutional adoption and potential to challenge major legacy financial markets. Investors are actively debating the token's infrastructure utility versus short-term price volatility, while closely monitoring its correlation with wider crypto-market cycles.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is trending as investors debate the impact of potential real-world asset tokenization and recent price volatility, leading to intense community division between those anticipating a major reversal and those warning of further downside. The conversation is heavily dominated by bearish sentiment, with participants actively discussing the dangers of holding positions amidst a perceived ongoing downtrend.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injective (INJ) is gaining traction as investors speculate on its potential for institutional adoption, driven by consistent network development and a strong deflationary buyback and burn model. The community is particularly focused on how the broader Injective ecosystem and its leading meme tokens could capture value as the chain matures and institutional interest increases.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum

Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum PR Newswire NEW YORK, May 28, 2026 USA News Group News CommentaryIssued on behalf ofAva Bio, Inc.As...

Sana Biotechnology (NASDAQ:SANA) Shares Down 7.3% - Time to Sell?

Sana Biotechnology (NASDAQ:SANA) Stock Price Down 7.3% - Here's What Happened...

Wall Street Zen Downgrades Sana Biotechnology (NASDAQ:SANA) to Strong Sell

Wall Street Zen lowered Sana Biotechnology from a "sell" rating to a "strong sell" rating in a research note on Saturday...

Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7% - What's Next?

Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7% - Here's Why...

Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of "Moderate Buy" from Analysts

Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are presently covering the company, MarketBeat.com...

Sana Biotechnology (NASDAQ:SANA) Shares Gap Up   - What's Next?

Sana Biotechnology (NASDAQ:SANA) Shares Gap Up - Here's What Happened...

Baillie Gifford & Co. Sells 4,827,438 Shares of Sana Biotechnology, Inc. $SANA

Baillie Gifford & Co. lessened its stake in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 42.2% in the 4th quarter, according to the company in its most recent 13F filing with the...

Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Tuesday

Stock futures mixed, Citigroup and Wells Fargo report earnings, Sana Biotechnology announces collaboration.read more...

SANA Stock Rallies 24% After Hours — How Much Is Mayo Clinic Investing In The Company?

Equity

Sana on Monday inked a strategic collaboration with Mayo Clinic aimed at advancing the development of its investigational cell therapy SC451 for type 1 diabetes.


Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines

Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines PR Newswire VANCOUVER, BC, April 6, 2026 Issued on behalf...

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Current Price	$3.30
Prev Close	$3.13
Open	$3.13
Dividend Yield	0.00%
50-Day Moving Average	$3.24
Beta	2.02
Avg. Volume	3.59M
PE Ratio	-3.51

52-Week High	$6.55
52-Week Low	$2.10
Market Capitalization	$918.36M
EPS (Annual)	-$0.9642
Price to Book	7.47
Revenue Per Employee	$0.00

SANA
Sana Biotechnology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest SANA News

SANASana Biotechnology Inc